Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | MRNA | BMY | AMGN | GILD |
| Company | Ascendis Pharma ADR | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 135.00 | 120.00 | 44.00 | 300.12 | 65.57 |
| High | 137.32 | 122.82 | 44.22 | 307.57 | 65.61 |
| Low | 133.52 | 119.50 | 43.56 | 298.89 | 64.76 |
| Last | 133.93 | 121.89 | 43.67 | 307.31 | 64.92 |
| Change | -2.05 | +0.82 | -0.37 | +7.01 | -0.54 |
| % Change | -1.51% | +0.68% | -0.84% | +2.33% | -0.82% |
| Volume | 389,300 | 2,507,500 | 11,928,300 | 2,859,500 | 5,134,900 |
| 20-Day Average Volume | 334,400 | 3,305,285 | 14,406,595 | 2,869,700 | 7,463,450 |
| Previous Close | 135.98 | 121.07 | 44.04 | 300.30 | 65.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 140.59 | 110.55 | 46.39 | 277.32 | 66.30 |
| 20-Day Raw Stochastic | 2.57% | 76.55% | 4.65% | 75.31% | 12.57% |
| 20-Day Relative Strength | 40.82% | 63.66% | 28.89% | 65.94% | 32.77% |
| Weighted Alpha | +40.86 | +8.94 | -36.84 | +32.33 | -21.04 |
| Today's Opinion | 8% Buy | 100% Buy | 100% Sell | 56% Buy | 100% Sell |
| Previous Opinion | 24% Buy | 100% Buy | 100% Sell | 40% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 88% Buy | 16% Sell | 8% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.02% since 05/01/24 | +9.36% since 05/01/24 | -1.22% since 05/01/24 | +10.79% since 05/01/24 | -0.90% since 05/01/24 |
| Low | 133.52 on 05/08/24 | 114.06 on 05/02/24 | 43.33 on 05/02/24 | 274.90 on 05/02/24 | 64.33 on 05/03/24 |
| High | 143.99 on 05/02/24 | 128.81 on 05/02/24 | 44.62 on 05/06/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 |
| 1-Month | |||||
| %Chg | -10.04% since 04/08/24 | +15.99% since 04/08/24 | -14.54% since 04/08/24 | +14.16% since 04/08/24 | -6.48% since 04/08/24 |
| Low | 133.39 on 04/26/24 | 99.30 on 04/22/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 156.84 on 04/10/24 | 128.81 on 05/02/24 | 51.68 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 |
| 3-Month | |||||
| %Chg | -3.82% since 02/08/24 | +30.14% since 02/08/24 | -10.35% since 02/08/24 | +4.23% since 02/08/24 | -12.03% since 02/08/24 |
| Low | 133.39 on 04/26/24 | 84.06 on 02/13/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 161.00 on 02/26/24 | 128.81 on 05/02/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 |
| 6-Month | |||||
| %Chg | +41.37% since 11/08/23 | +70.86% since 11/08/23 | -16.69% since 11/08/23 | +12.46% since 11/08/23 | -16.66% since 11/08/23 |
| Low | 86.54 on 11/13/23 | 67.62 on 11/13/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 |
| High | 161.00 on 02/26/24 | 128.81 on 05/02/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,917,298 | 46,398,864 | 89,273,480 | 161,091,424 | 81,502,736 |
| Shares Outstanding, K | 58,224 | 383,240 | 2,027,100 | 536,435 | 1,245,077 |
| Annual Sales | 288,670,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -521,070,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 104,110,000 | 167,000,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -142,260,000 | -1,175,000,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.54 | 1.57 | 0.45 | 0.60 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 05/02/24 | -3.07 on 05/02/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 41.81 | 16.08 | 16.26 |